Back to Authors

Ando, Yuta

Mayo Clinic

Integrated BioTherapeutics (United States)

Citations 1

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer
Hecht, J. Randolph, Sandberg, Mark, Wang, Xueyin , Martin, Aaron, Nampe, Daniel , Gabrelow, Grant B. , Li, Chuck, McElvain, Michele , Lee, Wen-Hua , Shafaattalab, Sanam , Martire, Sara , Fisher, F. , Ando, Yuta, Liu, Edwin , Ju, David, Hsin, Jing-Ping, Zampieri, Alexandre, Morelli, Maria Pia , Welling, Theodore H., Patel, Sandip Pravin , Welch, John S. , Go, William Y., Mardiros, Armen, Maloney, David G. , Wong, Lu-Min, Xu, Han , Molina, Julian R. , Ando, Yuta, Liu, Edwin, Ju, David, Simeone, Diane M. , Kopetz, Scott , Borad, Mitesh J. , Garon, Edward B. , Kirtane, Kedar , Locke, Frederick L. , Ng, Eric, Kamb, Alexander

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A242-A242

10.1136/jitc-2022-sitc2022.0229 Get It